BACKGROUND: A cycle day 3 FSH concentration is a popular screening tool for predicting success in achieving pregnancy after IVF. Difficulties interpreting this test have resulted from lack of consensus in defining an elevated FSH concentration, a change in the assays, and lack of controlling for factors which may confound the association between FSH concentration and pregnancy. METHODS: Assessment was made of the ability of a moderately elevated (10-11.4 mIU/ml, World Health Organization 2nd International Standard (IRP 78/549) and elevated FSH (>11.4 mIU/ml, conversion factor to SI units, 1.00) in predicting ability to achieve pregnancy through IVF and embryo transfer, both independently, and after controlling for confounding variables such as age, diagnosis, and response to gonadotrophins. RESULTS: A total of 293 IVF cycles were retrospectively reviewed. An FSH (>11.4) was strongly associated with inability to achieve pregnancy after IVF both independently (P < 0.01) and after multivariate analysis (P < 0.01), and had a strong predictive value (100%). A moderately elevated FSH (10-11.4) was not statistically associated with pregnancy outcome either independently or after multivariate analysis, and had a low predictive value (71%). CONCLUSIONS: Much of the predictive value of an elevated FSH is confounded by poor response to gonadotrophin stimulation, which may be overcome in younger women.
Introduction
As a woman ages, her ability to achieve pregnancy decreases moderately until age 35 years, then more rapidly thereafter (Barnhart and Osheroff, 1998) . The cycle day 3 FSH concentration is a popular screening tool for predicting success in an IVF cycle, independent of age, and was first proposed as such by Muasher (Muasher et al., 1988) . Since then, it has been demonstrated that women with an elevation of the day 3 FSH have declining ovarian function (Lenton et al., 1988) and decreased success at treatment with assisted reproductive techniques (Navot et al., 1987; Scott et al., 1989 Scott et al., , 1990 Tanbo et al., 1989; Toner et al., 1991; Khalifa et al., 1992; Pearlstone et al., 1992; Martin et al., 1996; Evers et al., 1998) . Several studies have shown that women with elevated FSH concentrations, independent of age, have a poor response to ovarian stimulation, resulting in lower pregnancy rates. Difficulties in the interpretation of this screening test have resulted from a lack of consensus in the definition of an elevated FSH concentration along with lack of controlling for factors that may confound the association of FSH concentration with pregnancy. Moreover, the interpretation of the literature is complicated by differences between assays used in individual
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laboratories and a change in the Second International Reference Preparation (Second IRP) from a human menopausal gonadotrophin (HMG) standard to a World Health Organization Second International Standard (IRP 78/549). To convert an FSH value (mIU/ml) from the 2nd IRP-HMG standard to the 2nd IRP 78/549 standard, one would multiply by 0.67. Conversely, to convert an FSH value (mIU/ml) from the 2nd IRP 78/549 standard to the 2nd IRP-HMG standard, one would multiply by 1.49.
One of the first large-scale studies evaluating the predictive value of the basal FSH categorized the threshold values as follows: low Ͻ15 mIU/ml; moderate 15-24.9 mIU/ml; high ജ25 mIU/ml (Scott et al., 1989) . This study demonstrated a declining pregnancy rate as basal FSH concentration increased, with a moderate decrease in pregnancy rate for women with an FSH between 15 and 24.9 mIU/ml, and a dramatic decrease in pregnancy rate if the FSH was ജ25 mIU/ml. Others (Licciardi et al., 1995; Evers et al., 1998) have used 17 mIU/ml as a cut-off to define an elevated basal FSH concentration. Converting these numbers to the new 78/549 standard results in a substantially lower FSH threshold. An FSH value of 25 mIU/ml would be equivalent to 16.7 mIU/ml (World Health Organization 78/549 standard), a value of 17 mIU/ml equivalent to 11.4 mIU/ml, and a value of 15 mIU/ml equivalent to 10 mIU/ml.
In this study, the predictive value of FSH at various concentrations was determined in order to identify the optimal cut-off. The cut-off values were defined to coincide with those established in the literature, taking into account the change in reference standard. The predictive ability of a moderately elevated and elevated day 3 FSH was evaluated, both independently and after controlling for confounding factors such as diagnosis, age, and follicular response to gonadotrophins.
Materials and methods
A chart review was conducted for 315 women who initiated an IVF cycle over a time period of February 1997 to November 1998 at the Division of Reproductive Endocrinology and Infertility of the University of Pennsylvania Medical Center. Because the data collected and analysed were obtained during the course of standard patient care, and did not affect patient treatment or confidentiality, review by the committee for the use of Human Subjects is exempt at our institution.
A total of 293 subjects (94%) was included whose records were complete. Cycle day 3 FSH concentrations were measured in all patients during a spontaneous cycle. All FSH concentrations from the previous 12 months were reviewed, and the highest value recorded was used as the FSH concentration in this study. Other information collected included: patient age, aetiology of infertility, medication used, number of ampoules used, day of human chorionic gonadotrophin administration, estradiol concentration on the day of human chorionic gonadotrophin (HCG) administration, endometrial thickness, whether intracytoplasmic sperm injection (ICSI) was performed, number of oocytes retrieved, number of embryos transferred, and whether or not pregnancy was achieved. All patients, regardless of age or FSH concentration, underwent stimulation.
Stimulation protocol
Ovulation induction was commenced with either a luteal phase or a flare protocol. In patients undergoing the luteal phase protocol, leuprolide acetate (Lupron; TAP Pharmaceuticals, Deerfield, IL, USA) was started at a dose of 10 U (0.5 mg) daily, 7-8 days after the LH surge. After the withdrawal bleed, the patient underwent baseline ultrasound, estradiol, and LH measurements to confirm ovarian suppression. The cycle was allowed to proceed if estradiol was Ͻ50 pg/ml (conversion factor to SI units, 3.67), LH was suppressed, and ultrasound demonstrated absence of cysts. Once gonadotrophins were started, the dose of Lupron was dropped to 5 units (0.25 mg) daily. Medications utilized by patients included: recombinant (rFSH, Gonal-F; Serono, Norwell, MA, USA), urinary FSH (uFSH, Metrodin; Serono), or highly purified (hp) FSH (Fertinex; Serono).
Patients utilizing the flare protocol started 5 units (0.25 mg) of Lupron daily on cycle day 1 with baseline ultrasound and blood work as above. If all was normal, the patients started gonadotrophins on cycle day 2.
Patients were brought back on cycle day 5-7 for ultrasound, estradiol, and LH measurements. Based on the results of the above tests, the medication dose was adjusted as necessary. HCG, 10 000 U (Profasi; Serono), was administered when the leading follicles were Ͼ20-22 mm in mean diameter with an appropriate estradiol concentration of~200 pg/ml per mature follicle. Ultrasound-guided oocyte retrieval was performed 36 h after HCG administration, and embryo transfer was performed on the third day post retrieval. The luteal phase was supported with progesterone in oil, 50 mg i.m. daily, starting the night of oocyte retrieval, and was continued until a negative pregnancy test was obtained or until week 10 of gestation. A serum HCG test was obtained 14 days following embryo transfer.
Definition of outcome
Pregnancy was defined using standard SART definitions. A pregnancy was classified as a chemical pregnancy if the initial HCG concentration exceeded 5 mIU/ml, but no sac was demonstrated on ultrasound. A live birth was defined as a pregnancy resulting in delivery of a viable infant. An ectopic gestation was defined as occurring outside the endometrial cavity, and a spontaneous abortion was defined as a pregnancy lost before week 20 of gestation.
In order to evaluate the predictive value of different ages and FSH values, the data were subdivided into age categories as follows: Ͻ35, 35-40 and Ͼ40 years, and FSH categories of normal (Ͻ10 mIU/ml, conversion factor to SI units, 1.00), moderately elevated (10-11.4 mIU/ml), elevated (Ͼ11.4 mIU/ml) and markedly elevated (Ͼ16.7 mIU/ml). These categories were chosen to reflect concentrations of FSH demonstrated to be predictive in other studies, adjusting for the reference preparations used in the respective assays (Scott et al., 1989; Licciardi et al., 1995; Evers et al., 1998) .
Data analysis
Descriptive analyses were first conducted in the total eligible cohort to examine baseline associations and to assess whether the distributions of continuous variables were consistent with the assumption of normality required for parametric statistical tests. Associations between live births and FSH value, and between live births and other variables, were assessed using odds ratios (OR) calculated using STATA software (College Park, TX, USA). A variable was considered a significant predictor of pregnancy if the 95% confidence interval of the OR did not include 1.0. The sensitivity, specificity, and predictive values were calculated. Multiple 2ϫ2 tables were utilized to obtain the percentage values for sensitivities, specificities, and positive and negative predictive values, with disease defined as not achieving a live birth. Separate tables were constructed to evaluate the sensitivity and predictive value of an FSH concentration at the cut-off value used in this study. The test characteristics of an elevated FSH value were calculated using each cut-off point (Ͼ10.0 and Ͼ11.4) in the entire population. In order to assess the utility of using an FSH cut-off value of Ͼ10, assuming an elevated FSH was predictive, the test characteristics of an FSH value of Ͼ10.0, excluding women with an elevated FSH value (Ͼ11.4), were also evaluated. All calculations were conducted on the entire sample and in subgroups stratified by age and FSH concentration.
Both unadjusted and stratified analyses were also performed to identify potential confounding variables to the outcome of achieving a live birth. Multivariable logistic regression was then used to estimate the OR for the association of FSH value (above a given cut-off point) and pregnancy, adjusted for all potential confounders. Variables were included in the logistic regression model if: (i) they were biologically plausible, (ii) they demonstrated a P Ͻ 0.20 for the association with outcome in the unadjusted analyses, or (iii) adjustment for the given variable changed the OR for the association of FSH with pregnancy by 10% (Mickey and Greenland, 1989; Maldonado and Greenland, 1993) . P Ͻ 0.05 was considered statistically significant using twotailed tests. Data are presented as mean Ϯ SD unless otherwise specified.
Laboratory procedures
FSH concentration was determined using the Bayer Technicon Immuno 1 System, a heterogeneous sandwich magnetic separation 
Results
Each subject had an average of one to six FSH values recorded in the chart in the 12 months prior to the initiation of the IVF cycle. Based on the maximum FSH value, the cohort of 293 patients was divided into FSH categories as follows: normal: FSH Ͻ10 mIU/ml (mean FSH value 7.0 Ϯ 1.5, n ϭ 245); moderately elevated: FSH 10-11.4 mIU/ml (mean FSH value 10.7 Ϯ 0.4, n ϭ 24); and elevated: FSH Ͼ11.4 mIU/ml (mean FSH value 16.2 Ϯ 5.3, n ϭ 24). There were only seven subjects with an FSH Ͼ16.7 mIU/ml, so these subjects were included in the Ͼ11.4 mIU/ml group. The mean FSH concentration in each group was significantly different (P Ͻ 0.001). The average age in each FSH group was similar (normal, 35.0 Ϯ 4.5; moderately elevated, 36.0 Ϯ 2.8; elevated, 36.0 Ϯ 4.2). The percentage of patients Ͻ35, 35-40 and Ͼ40 years of age was similar in all FSH groups with the exception of a trend toward a greater percentage of women Ͼ40 years in the elevated FSH group (30.4%) compared with the moderately elevated (12%) and normal FSH group (17.6%). There was no significant difference in the percentage of patients who had no prior IVF cycles versus those who had at least one prior cycle between FSH groups. The response to stimulation, stratified by age and FSH, is listed in Table I . There were a total of 104 pregnancies in the 293 patients *FSH mIU/ml (2nd IRP 78/549 standard). Significant statistical comparisons using χ 2 analysis are denoted with equivalent numerical superscripts below. a Total detectable HCG rate in women Ͻ35 years with an FSH Ͻ10 mIU/ml compared with women 35-39 years with an FSH Ͻ10 mIU/ml, P Ͻ 0.03. b Total detectable HCG rate in women Ͻ35 years with an FSH Ͻ10 mIU/ml compared with women ജ40 years with an FSH Ͻ10 mIU/ml, P Ͻ 0.002.
studied. Seventy-six of these pregnancies resulted in a live birth, two were ectopic pregnancies, 13 resulted in a spontaneous abortion, and 13 were biochemical pregnancies. The overall pregnancy rate (as measured by increased HCG; HCG ϩ ) rate per initiated cycle was 35.5%. Total HCG ϩ rates and live birth rates stratified by both age and FSH value are presented in Table II . Overall HCG ϩ rates and live birth rates by age (all FSH groups combined) were: age Ͻ35 years: 46.9 and 34.4%; age 35-40 years: 30.5 and 23.7%; age Ͼ40 years: 11.8 and 2.9%. Overall HCG ϩ rates and live birth rates by FSH (all age groups combined) were: FSH Ͻ10 mIU/ml: 37.1 and 28.2%; FSH 10-11.4 mIU/ml: 37.5 and 29.2%; FSH Ͼ11.4 mIU/ml: 16.7 and 0%. In patients Ͻ35 years of age, the cycle cancellation rate The sensitivity, specificity, positive, and negative predictive values for a moderately elevated FSH (10-11.4 mIU/ml), an elevated FSH (Ͼ11.4 mIU/ml) value in all women, and for an FSH value Ͼ10 mIU/ml, excluding women with a value Ͼ11.4 mIU/ml, are presented in Table III . Data is presented overall, and stratified by age. The sensitivity of a moderately elevated and elevated FSH value in predicting IVF failure is low for all age groups (6.7-19.5%). Specificity of moderately elevated and elevated FSH concentrations for all age groups is high, ranging from 90.1 to 100%. The positive predictive value of a moderately elevated FSH concentration ranges from 60 to 100%. The positive predictive value of an elevated FSH was 100%.
Significant predictors of pregnancy in women with a moderately elevated and an elevated FSH are listed in Table IV. Variables are listed if they were predictive in the entire cohort (without controlling for confounding variables) and after multiple logistic regression to control for confounding variables. Neither specific infertility diagnosis nor the use of ICSI was predictive of pregnancy outcome. A moderately elevated FSH was not predictive of outcome in either the unadjusted or adjusted analysis. An elevated FSH was predictive both in the unadjusted and adjusted analysis. Response to stimulation (number of oocytes retrieved, maximum estradiol concentration) was predictive of pregnancy in the unadjusted 121 analysis in both women with a moderately elevated and elevated FSH value. Only a high FSH (Ͼ11.4 mIU/ml) and age were predictive of outcome after controlling for confounding factors.
Discussion
The ability of a cycle day 3 FSH concentration to predict IVF outcome can be assessed in two distinct ways: clinically and statistically. It was found that, using either criterion, only an elevated basal FSH Ͼ11.4 mIU/ml, using the WHO 78/549 standard, was significantly associated with poor prognosis in IVF. A moderately elevated FSH (10-11.4 mIU/ ml) was not significantly associated with poor prognosis in IVF and had limited predictive ability.
Clinically, a basal day 3 FSH is commonly used as a screening tool to assess the prognosis of achieving a live birth with IVF. In this case, a clinician uses an FSH value prior to ovarian stimulation, without knowledge of response to gonadotrophin stimulation. Thus, prognosis is based solely upon the FSH concentration. A screening test used to identify those with a poor prognosis would optimally identify fertile patients (high specificity) as well as infertile patients (high sensitivity) (Barnhart and Osheroff, 1998) . However, screening tests often sacrifice either sensitivity or specificity in order to maximize the other (Barnhart and Osheroff, 1999) . The data presented here confirm that a day 3 FSH has a high specificity but a poor sensitivity (Barnhart and Osheroff, 1998) . Specifically, it was demonstrated that an elevated FSH had the highest sensitivity in women Ͼ35 years of age. However, this sensitivity was only 11.3%. Conversely, it was confirmed that FSH is a very specific screening test, as Ͼ90.1% of women who did achieve a live birth did not have an elevated FSH. In our series, no woman with an FSH Ͼ11.4 mIU/ml achieved a live birth. Conversely, an FSH of 10-11.4 mIU/ml did not predict IVF failure in up to 37% of patients. Based on these data, the use of FSH as a screening test is best employed to provide prognostic information for a patient undergoing IVF for the first time using a high cut-off concentration (Ͼ11.4 mIU). The goal of this paper was to evaluate the usefulness of a moderately elevated FSH and an elevated FSH value beyond the traditional 2ϫ2 tables. This was accomplished using logistic regression, assessing the association of an elevated FSH concentration with the ability to achieve a live birth. The use of multivariate analysis allows a statistical evaluation of the association of an elevated FSH to IVF success, while accounting for other factors that may confound outcome. The data presented here demonstrate that without controlling for confounding variables, many factors are statistically associated with the likelihood of achieving pregnancy including: an FSH Ͼ11.4 mIU/ml, age, maximum estradiol concentration, length of stimulation, and the number of oocytes retrieved. Therefore, each could serve as an independent predictor of pregnancy outcome. Many of these variables are inter-related and interdependent. Controlling for these factors with logistic regression demonstrates that a moderately elevated FSH (Ͼ10 mIU/ml) is not significantly associated with failure to achieve a live birth after IVF. Only an elevated FSH (Ͼ11.4 mIU/ml) and age are significantly associated with failure to achieve a live birth after IVF. Without controlling for these variables, the data could have been misleading, and would have been subject to many of the biases limiting other manuscripts evaluating the usefulness of FSH as a predictor of treatment outcome. The current data are consistent with recent studies (Bancsi et al., 2000) but contrast with the results of others who have demonstrated that age predicts pregnancy more strongly than FSH (Sharif et al., 1998) . Thus, while an elevated FSH (Ͼ11.4 mIU/ml) is an independent predictor of pregnancy, poor prognosis can also be identified on the basis of age and/ or prior stimulation response. In other words, if information on these factors is known to the clinician, the additional information obtained with a day 3 FSH is limited.
An important aspect of the current study is that not only was the FSH value just prior to the IVF cycle assessed, but all baseline FSH values were obtained in the preceding 12 months. The highest FSH value recorded was used for analysis. A large variability in values over this time period was noted. The highest value was more predictive of outcome than the FSH immediately preceding the IVF cycle (data not shown). This is consistent with a prior study demonstrating that the chance of pregnancy after an IVF cycle is dramatically decreased in patients with any previous history of an elevated day 3 FSH concentration (Martin et al., 1996) .
In conclusion, comparing the results of studies evaluating the predictive value of FSH is problematic. Differences in assays, techniques, and reference preparations exist, such as the change in the Second IRP from the older HMG standard to the newer 78/ 549 standard. For example, an FSH of 10 mIU/ml (78/549 standard) equals 15 mIU/ml (HMG standard), and an FSH of 11.4 mIU/ml (78/549 standard) equals 17 mIU/ml (HMG standard). The data presented here demonstrate that a day 3 FSH is only predictive of IVF failure when it is elevated (Ͼ11.4 mIU/ ml, WHO 2nd IRP 78/549 standard). A moderately elevated FSH concentration (10-11.4 mIU/ml) does not have any independent predictive ability. Moreover, much of the predictive value of an elevated FSH is confounded by other variables that affect IVF success such as age, infertility diagnosis, and response to stimulation with gonadotrophins. The poor prognosis conferred by an elevated FSH in younger women (Ͻ35 years) may be overcome by maximizing the stimulation protocol.
